Xiangcai Co.,Ltd (SHA:600095)

Lumos Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31,118	20,536	21,472	21,583	28,892	39,157
Market Cap Growth	10.55%	-4.36%	-0.51%	-25.30%	-26.21%	1003.76%
Last Close Price	10.91	7.20	7.47	7.46	9.80	14.05
PE Ratio	459.64	188.12	179.81	-	59.48	109.89
PS Ratio	17.46	11.91	11.80	7.21	7.21	17.79
PB Ratio	2.62	1.73	1.80	1.82	2.30	3.68
P/FCF Ratio	10.55	3.58	-	28.68	-	211.48
P/OCF Ratio	10.33	3.54	-	25.72	-	153.57
Debt / Equity Ratio	0.94	0.88	0.83	0.91	0.76	0.89
Debt / FCF Ratio	3.77	1.81	-	14.40	-	51.20
Asset Turnover	0.05	0.05	0.05	0.09	0.12	0.07
Quick Ratio	0.83	1.11	1.20	1.36	1.39	1.29
Current Ratio	1.34	1.34	1.36	1.57	1.54	1.38
Return on Equity (ROE)	0.55%	0.89%	0.98%	-2.68%	4.20%	3.58%
Return on Assets (ROA)	0.17%	0.29%	0.34%	-0.94%	1.46%	1.19%
Earnings Yield	0.22%	0.53%	0.56%	-1.51%	1.68%	0.91%
FCF Yield	9.48%	27.95%	-7.06%	3.49%	-1.58%	0.47%
Dividend Yield	0.32%	-	0.47%	0.92%	1.36%	0.53%
Payout Ratio	689.72%	409.48%	442.72%	-	106.21%	86.09%
Buyback Yield / Dilution	-0.01%	-0.03%	-0.08%	-3.67%	-5.10%	-1.72%
Total Shareholder Return	0.31%	-0.03%	0.39%	-2.74%	-3.74%	-1.19%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.